EMILY BERGERON: Open Payments
NPI 1295379576 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,158 in 140 payments from 16 companies in 2025. Trend: 2023 $3,567 · 2024 $3,035 · 2025 $3,158
Food & beverage: $3,098Education: $60
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 44 | $831 |
| ABBVIE INC. | 26 | $576 |
| Novartis Pharmaceuticals Corporation | 16 | $216 |
| UCB, Inc. | 10 | $211 |
| Lilly USA, LLC | 6 | $190 |
| GlaxoSmithKline, LLC. | 3 | $183 |
| GENZYME CORPORATION | 2 | $169 |
| Mallinckrodt Hospital Products Inc. | 6 | $169 |
| AstraZeneca Pharmaceuticals LP | 4 | $136 |
| E.R. Squibb & Sons, L.L.C. | 7 | $132 |
Products named: RINVOQ, Otezla, COSENTYX, Bimzelx, TALTZ, BENLYSTA, EVENITY, KEVZARA.
Industry payments across LA — which companies pay providers there.
